MedTrace Logo

Validation of 5-Point Investigator Global Assessments for Pemphigus

NCT05534776 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-09-19

No results posted yet for this study

Summary

This study aims to explore the reliability and validity of newly developed Investigator Global Assessments (IGAs) in scoring the severity of pemphigus. IGAs are simple 5-point scales ranging from clear - severe and are preferred by the FDA as endpoints in clinical trials.

Conditions

  • Pemphigus

Interventions

OTHER

Investigator Global Assessments (IGAs)

5-Point scale from 0-4 to score the severity of pemphigus, where 0=clear, 1=almost clear, 2=mild, 3=moderate and 4=severe.

Sponsors & Collaborators

  • Premier Specialists, Australia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-21
Primary Completion
2023-08-30
Completion
2023-08-30

Countries

  • Australia
  • Bulgaria
  • Greece
  • Iran
  • Israel
  • Singapore
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534776 on ClinicalTrials.gov